Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on NASDAQ
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on NASDAQ
Today’s data is for companies listed on the NASDAQ.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| GOOG | Alphabet Inc | 2018 | 1231.150000 | 1335.9090 | USD | 11 |
| AVGO | Broadcom Inc | 2019 | 214.430000 | 307.0833 | USD | 12 |
| BKNG | Booking Holdings Inc | 2018 | 1931.230000 | 2121.0000 | USD | 5 |
| CHTR | Charter Communications Inc | 2018 | 305.030000 | 383.4000 | USD | 5 |
| LRCX | Lam Research Corp | 2019 | 174.140000 | 248.2857 | USD | 7 |
| WB | Weibo Corp | 2018 | 80.100000 | 142.0000 | USD | 2 |
| MELI | MercadoLibre Inc | 2018 | 378.180000 | 420.0000 | USD | 1 |
| IPGP | IPG Photonics Corp | 2018 | 170.660000 | 218.5000 | USD | 6 |
| ZBRA | Zebra Technologies Corp | 2018 | 169.980000 | 207.0000 | USD | 2 |
| SAGE | Sage Therapeutics Inc | 2018 | 158.480000 | 240.5000 | USD | 2 |
| SINA | SINA Corp | 2018 | 72.070000 | 111.0000 | USD | 2 |
| RGLD | Royal Gold Inc | 2019 | 77.090000 | 134.3778 | CAD | 2 |
| STMP | Stamps.com Inc | 2018 | 238.350000 | 305.0000 | USD | 1 |
| MDGL | Madrigal Pharmaceuticals Inc | 2018 | 242.800000 | 326.2500 | USD | 4 |
| GBT | Global Blood Therapeutics Inc | 2018 | 50.050000 | 98.3333 | USD | 3 |
| TLND | Talend SA | 2018 | 63.810000 | 120.0000 | USD | 1 |
| TSRO | Tesaro Inc | 2018 | 31.490000 | 81.5000 | USD | 4 |
| BGNE | BeiGene Ltd | 2018 | 177.760000 | 216.3000 | USD | 2 |
| RDUS | Radius Health Inc | 2018 | 20.600000 | 58.0000 | USD | 1 |
| VRTS | Virtus Investment Partners Inc | 2018 | 128.050000 | 175.0000 | USD | 1 |
| OSTK | Overstock.com Inc | 2018 | 30.625000 | 112.0000 | USD | 1 |
| USCR | US Concrete Inc | 2018 | 48.450000 | 95.0000 | USD | 1 |
| ADMS | Adamas Pharmaceuticals Inc | 2018 | 22.280000 | 68.0000 | USD | 2 |
| ALBO | Albireo Pharma Inc | 2018 | 31.870000 | 86.0000 | USD | 1 |
| PRTK | Paratek Pharmaceuticals Inc | 2018 | 10.000000 | 52.5000 | USD | 2 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
WB:NAS Weibo
http://ir.weibo.com
Weibo has 3361 employees and is headquartered in China.
Weibo Corp operates in the internet content industry in China. It offers a social media platform for people to create, distribute and discover Chinese-language content.
MELI:NAS MercadoLibre
http://www.mercadolibre.com
MercadoLibre has 5582 employees and is headquartered in Argentina.
MercadoLibre Inc is an e-commerce company. It hosts the online commerce platform in Latin America, which is focused on enabling e-commerce and its related services. The company generates most of its revenue from Brazil, Argentina, Venezuela, and Mexico.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.